Replies to post #706424 on NorthWest Biotherapeutics Inc (NWBO)

[Arby2000]

Doc: You just posted the rest of the story behind ExW's previous misleading post where he cherry-picked the parts that supported the narrative he wanted to push.

[exwannabe]

We know the Medicenna trial control arm will consist of 50 patients randomized within the trial plus 100 patients from Medidata's database of 9M patients. 100 would be enough for NWBO's ECA. Not clear how many matches would be available, but certainly it is not impossible to find 100.

No, I would not expect NWBO to go back and change anything. They spent a couple years deciding what comparator they could use to give them the best shot on goal.

And no, that the SAP was accepted does not in any way means the FDA considers it worthy of getting -:L approved. The vast majority of SAPs are not for approval, yet the FDA accepts them.

[iclight]

You obviously haven’t spent more than 20 seconds googling Medicenna’s ECA. Try a bit more work before spouting off nonsense. Meditate AI is thorough and detailed in explaining their ECA database complete patient level data from BP trials and smaller trials. That’s literally what patient level data is. Try and Google that and less run on word salad.



They also legitimately respond to questions. And BTW, Medicenna doesn’t hide information for FOIA requests like NWBO does. They buried all information on the futility rec because they didn’t want anyone to find out more about it. Typical shady actions from a shady company.